Aktienanalyse zu Trulieve Cannabis Corp (TRLV)TRLVTrulieve Cannabis Corp

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Each of its three regional hubs is anchored by market positions in the cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require expertise in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including supercritical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, it utilizes distillation, purification, and manufacturing technologies to further refine extracts and transform them into a wide variety of finished products. Its brands include premium-tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers. It operates in the Healthcare sector.

Trulieve Cannabis Corp is a good buy right now due to its current price of $11.82, which is significantly below the analyst price target of $15, indicating a potential upside of 27.5%. Additionally, the stock has shown strong momentum with a 5-day change of +6.49% and a high RSI of 79.616, suggesting bullish sentiment. However, investors should be cautious of the recent net income drop to -405.975 million in Q2 2026, which poses a risk to profitability.